Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM)

CUSIP: 230031106

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
59,091,689
Total 13F shares
63,191,497
Share change
+1,996,525
Total reported value
$653,881,687
Put/Call ratio
21%
Price per share
$10.35
Number of holders
152
Value change
+$34,293,716
Number of buys
89
Number of sells
58

Quarterly Holders Quick Answers

What is CUSIP 230031106?
CUSIP 230031106 identifies CGEM - Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM) as of Q4 2025

As of 31 Dec 2025, Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM) was held by 152 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 63,191,497 shares. The largest 10 holders included Lynx1 Capital Management LP, MPM BIOIMPACT LLC, BVF INC/IL, BlackRock, Inc., VANGUARD GROUP INC, Kynam Capital Management, LP, Blue Owl Capital Holdings LP, STATE STREET CORP, Affinity Asset Advisors, LLC, and RTW INVESTMENTS, LP. This page lists 152 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.